期刊文献+

儿童心肌炎危险分层和预后分析 被引量:4

Risk stratification and prognosis analysis of children with myocarditis
原文传递
导出
摘要 目的分析心脏磁共振成像(CMR)高危心肌炎儿童的临床特点、治疗和预后。方法选择首都医科大学附属北京安贞医院儿科自2018年1月至2019年7月收治的70例心肌炎儿童进行回顾性队列研究,CMR显示为心肌水肿和(或)晚期钆增强的患儿为CMR高危组(29例),CMR未见明显异常的患儿为CMR对照组(41例),比较两组心肌炎儿童的临床资料、治疗情况和随访时不良心血管事件发生率。Cox回归分析影响预后的危险因素。结果 70例心肌炎儿童中,男43例(61.4%),女27例(38.6%),平均年龄(7.6±5.3)岁(5~18岁)。两组的胸痛、乏力和胸闷等临床症状发生率差异无统计学意义(均P>0.05),但基础肌酸激酶-MB、心肌肌钙蛋白Ⅰ和左心室射血分数等差异均有统计学意义(均P<0.05),应用激素和卡托普利治疗的比例差异亦有统计学意义(均P<0.05)。平均随访3.7个月,17例患儿发生不良心血管事件,两组间不良心血管事件的发生率差异有统计学意义(31.0%vs. 19.5%,P<0.05)。Cox回归分析结果显示,高危CMR表现和心肌肌钙蛋白Ⅰ是影响不良心血管事件的危险因素。结论 CMR高危心肌炎儿童的临床表现虽多不典型,但病情重;虽加用激素和卡托普利等积极治疗,但短期随访时的不良心血管事件发生率仍较高,因此,需重视CMR高危心肌炎儿童的筛查、监护、治疗和随访。 ObjectiveTo evaluate the clinical and therapeutic characteristics and prognosis in high-risk children withmyocarditis assessed by cardiac magnetic resonance(CMR).MethodsA retrospective cohort study was performed in seventychildren with myocarditis,who were treated in Department of Pediatrics,Beijing Anzhen Hospital of Capital Medical Universityfrom January 2018 to July 2019. Children with the presence of myocardium edema and/or late gadolinium enhancement inCMR were in the high-risk CMR group(n=29)and those without CMR abnormalities were in the CMR control group(n=41). Clinical characteristics,treatment and rate of adverse cardiovascular events during the follow-up were compared betweenthe two groups. Cox regression analysis was used to evaluate the risk factor for prognosis.ResultsAmong the 70 children(aged 5 to 18 years,mean age 7.6±5.3),43 were male(61.4%)and 27 were female(38.6%). The incidences of chest pain,fatigue and chest distress were similar between the two groups(P>0.05). However,there were significant differences in thelevels of serum creatinine kinase MB,cardiac troponinⅠ,and left ventricular ejection fraction between the two groups(allP<0.05). Moreover,children in the high-risk CMR group were more likely to use the steroids and captopril(all P<0.05).After 3.7 months of follow-up,the rates of adverse cardiovascular events was significantly different between the two groups(31.3% vs. 19.5%,P<0.05). Cox regression analysis results showed that CMR high-risk images and cardiac troponinⅠ werethe risk factors for adverse cardiovascular events.ConclusionChildren with high-risk CMR images of myocarditis oftenhave no typical clinical demonstrations,but they are in a severe condition;although steroids and captopril were used for activetreatment,the incidence of adverse cardiovascular events is high in short-term follow-up. Therefore,early screening,monitoring,treatment and follow-up should be given greatattention in patients with high risk CMR images of myo-carditis.
作者 杨曦 李佳 刘桂英 YANG Xi;LI Jia;LIU Gui-ying(Department of Pediatrics,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处 《中国实用儿科杂志》 CSCD 北大核心 2020年第8期610-614,共5页 Chinese Journal of Practical Pediatrics
基金 国家重大科学仪器设备开发专项(2013YQ03092306) 北京市科技计划项目(Z111107067311030) 北京市临床重点专科建设项目(2-1-2-18-300)。
关键词 心肌炎 危险分层 心脏磁共振成像 激素治疗 预后 myocarditis risk stratification cardiac mag-netic resonance imaging hormone treatment prognosis
  • 相关文献

参考文献6

二级参考文献62

  • 1邓海燕,黄国英,马晓静,梁雪村,林其珊,孙斌,陈伟达,陶子喻.1344名正常小儿超声心动图参数和心功能指标测量值[J].中国临床医学影像杂志,2006,17(6):301-303. 被引量:11
  • 2吴铁吉.病毒性心肌炎诊断标准[J].中华儿科杂志,2000,38(2):75-75.
  • 3Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children [ J]. JAMA, 2006, 296 ( 15 ) : 1867 - 1876.
  • 4Richardson P, Mekenna W, Bristow M, et al. Report of the 1995 World Health Organization/ntemational Society and Federation of cardiology task force on the definition and classification of cardiomyopathy[ J]. Circ J, 1996,93 (5) : 841 - 842.
  • 5Gesuete V, Ragali L, Prandstraller D, et al. Dilated cardiomyopathy presenting in childhood : Aetiology, diagnostic approach, and clinical course [ J ]. Cardiol Young,2010,20 (6) :680 - 685.
  • 6Harmon WG, Sleeper LA, Cuuiberti L,et al. Treating children with idiopathic dilated cardiomyopathy (from the pediatric eardiomyopathy registry) [J] .Am J Cardiol,2009,104(2) :281 -286.
  • 7Speziale G, Nasso G, Piancone F, et al. One-year results after implantation of the CorCap for dilated cardiomyopathy and heart failure[ J]. Ann Thorac Surg ,2011,91 (5) : 1356 - 1362.
  • 8Hershberger RE, Norton N, Morales A, et al. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy[J]. Circ Cardiovasc Genet ,2010,3 (2) : 155 - 161.
  • 9Kimura A. Contribution of genetic factors to the pathogenesis of dilated cardiomyopathy. The cause of dilated cardiomyopathy: Genetic or acquired? ( Genetic - Side) [J]. Circ J,2011,75 (7) : 1756 - 1765.
  • 10Jefferies JL, Towbin JA. Dilated cardiomyopathy [ J ]. Lancet, 2010,375 (9716) :752 -762.

共引文献124

同被引文献28

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部